Patient-specific issues

Author(s):  
Philip Wiffen ◽  
Marc Mitchell ◽  
Melanie Snelling ◽  
Nicola Stoner

This chapter covers patient-specific issues related to children, older people, injecting drug users, and surgical patients. For children, drug pharmacokinetics and pharmacodynamics and dose calculations are reviewed. The specific concerns around adherence and also medicines licensing in children are covered. For older people, the topics include pharmacokinetics, pharmacokinetics, and medication review. Guidance is given on managing injecting drug users, especially in an in-patient setting, including a suggested regimen for titration of methadone to avoid opioid withdrawal. For surgical patients, the topics covered include management of regular medicines during the nil-by-mouth period, drug interactions with perioperative drugs, and a brief description of the impact of selected drugs in the perioperative period.

1992 ◽  
Vol 3 (4) ◽  
pp. 288-290 ◽  
Author(s):  
M Frischer ◽  
M Bloor ◽  
S Green ◽  
D Goldberg ◽  
R Covell ◽  
...  

Evidence of reduced levels of needle sharing among injecting drug users (IDUs) has largely been confined to IDUs attending needle exchanges or receiving treatment. In this paper we present the results of a serial cross-sectional study of needle sharing conducted in Glasgow using a multisite sampling strategy. Of the estimated 9400 IDUs in the city, 503 were interviewed in 1990 and 535 in 1991. The proportion of IDUs reporting injecting with, or passing on used needles and syringes in the last 6 months fell significantly as did the number of individuals from whom equipment was received or passed on to. The impact of this level of sharing has been limited in terms of HIV transmission; the prevalence of HIV among the 1990 sample was 2.0% and 1.1% for the 1991 sample. However, the fact that a third of IDUs in Glasgow continue to inject, even occasionally, with used equipment gives cause for concern in view of the other pathologies known to be associated with poor injecting hygiene.


Author(s):  
Anne-Déborah Bouhnik ◽  
Margaret Chesney ◽  
Patrizia Carrieri ◽  
Hervé Gallais ◽  
Jacques Moreau ◽  
...  

Addiction ◽  
2011 ◽  
Vol 106 (11) ◽  
pp. 1978-1988 ◽  
Author(s):  
Katy M. E. Turner ◽  
Sharon Hutchinson ◽  
Peter Vickerman ◽  
Vivian Hope ◽  
Noel Craine ◽  
...  

AIDS ◽  
1996 ◽  
Vol 10 (14) ◽  
pp. 1719-1728 ◽  
Author(s):  
Martin Y. Iguchi ◽  
Donald A. Bux ◽  
Victor Lidz ◽  
John F. French ◽  
Robert C. Baxter ◽  
...  

2012 ◽  
Vol 141 (3) ◽  
pp. 563-572 ◽  
Author(s):  
M. RONDY ◽  
L. WIESSING ◽  
S. J. HUTCHINSON ◽  
C. MATHEÏ ◽  
F. MATHIS ◽  
...  

SUMMARYMonitoring injecting drug users' (IDUs) health is challenging because IDUs form a difficult to reach population. We examined the impact of recruitment setting on hepatitis C prevalence. Individual datasets from 12 studies were merged. Predictors of HCV positivity were sought through a multilevel analysis using a mixed-effects logistic model, with study identifier as random intercept. HCV prevalence ranged from 21% to 86% across the studies. Overall, HCV prevalence was higher in IDUs recruited in drug treatment centres compared to those recruited in low-threshold settings (74% and 42%, respectively, P < 0·001). Recruitment setting remained significantly associated with HCV prevalence after adjustment for duration of injecting and recent injection (adjusted odds ratio 0·7, 95% confidence interval 0·6–0·8, P = 0·05). Recruitment setting may have an impact on HCV prevalence estimates of IDUs in Europe. Assessing the impact of mixed recruitment strategies, including respondent-driven sampling, on HCV prevalence estimates, would be valuable.


Sign in / Sign up

Export Citation Format

Share Document